Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

Aimée R Kreimer; Anil K Chaturvedi; Laia Alemany; Devasena Anantharaman; Freddie Bray; Mary Carrington; John Doorbar; Gypsyamber D'Souza; Carole Fakhry; Robert L Ferris; Maura Gillison; D Neil Hayes; Allan Hildesheim; Shao Hui Huang; Luiz P Kowalski; Krystle A Lang Kuhs; James Lewis; Douglas R Lowy; Hisham Mehanna; Andy Ness; Michael Pawlita; Maisa Pinheiro; John Schiller; Meredith S Shiels; Joseph Tota; Lisa Mirabello; Saman Warnakulasuriya; Tim Waterboer; William Westra; Stephen Chanock; Paul Brennan

doi:10.1016/j.oraloncology.2020.104736

Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

Aimée R Kreimer, Anil K Chaturvedi, Laia Alemany, Devasena Anantharaman, Freddie Bray, Mary Carrington, John Doorbar, Gypsyamber D'Souza, Carole Fakhry, Robert L Ferris, Maura Gillison, D Neil Hayes, Allan Hildesheim, Shao Hui Huang, Luiz P Kowalski, Krystle A Lang Kuhs, James Lewis, Douglas R Lowy, Hisham Mehanna, Andy NessMichael Pawlita, Maisa Pinheiro, John Schiller, Meredith S Shiels, Joseph Tota, Lisa Mirabello, Saman Warnakulasuriya, Tim Waterboer, William Westra, Stephen Chanock, Paul Brennan

Research output: Contribution to journal › Article (Academic Journal) › peer-review

60 Citations (Scopus)

Abstract

Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.

Original language	English
Pages (from-to)	104736
Journal	Oral Oncology
Volume	108
Early online date	2 Jun 2020
DOIs	https://doi.org/10.1016/j.oraloncology.2020.104736
Publication status	Published - 1 Sept 2020

Bibliographical note

Published by Elsevier Ltd.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.oraloncology.2020.104736

Handle.net

Persistent link

Cite this

Kreimer, A. R., Chaturvedi, A. K., Alemany, L., Anantharaman, D., Bray, F., Carrington, M., Doorbar, J., D'Souza, G., Fakhry, C., Ferris, R. L., Gillison, M., Neil Hayes, D., Hildesheim, A., Huang, S. H., Kowalski, L. P., Lang Kuhs, K. A., Lewis, J., Lowy, D. R., Mehanna, H., ... Brennan, P. (2020). Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncology, 108, 104736. https://doi.org/10.1016/j.oraloncology.2020.104736

@article{546ddfd1f96640709e0a20929e634a60,

title = "Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI",

abstract = "Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.",

author = "Kreimer, \{Aim{\'e}e R\} and Chaturvedi, \{Anil K\} and Laia Alemany and Devasena Anantharaman and Freddie Bray and Mary Carrington and John Doorbar and Gypsyamber D'Souza and Carole Fakhry and Ferris, \{Robert L\} and Maura Gillison and \{Neil Hayes\}, D and Allan Hildesheim and Huang, \{Shao Hui\} and Kowalski, \{Luiz P\} and \{Lang Kuhs\}, \{Krystle A\} and James Lewis and Lowy, \{Douglas R\} and Hisham Mehanna and Andy Ness and Michael Pawlita and Maisa Pinheiro and John Schiller and Shiels, \{Meredith S\} and Joseph Tota and Lisa Mirabello and Saman Warnakulasuriya and Tim Waterboer and William Westra and Stephen Chanock and Paul Brennan",

note = "Published by Elsevier Ltd.",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/j.oraloncology.2020.104736",

language = "English",

volume = "108",

pages = "104736",

journal = "Oral Oncology",

issn = "1368-8375",

publisher = "Elsevier Limited",

}

Kreimer, AR, Chaturvedi, AK, Alemany, L, Anantharaman, D, Bray, F, Carrington, M, Doorbar, J, D'Souza, G, Fakhry, C, Ferris, RL, Gillison, M, Neil Hayes, D, Hildesheim, A, Huang, SH, Kowalski, LP, Lang Kuhs, KA, Lewis, J, Lowy, DR, Mehanna, H, Ness, A, Pawlita, M, Pinheiro, M, Schiller, J, Shiels, MS, Tota, J, Mirabello, L, Warnakulasuriya, S, Waterboer, T, Westra, W, Chanock, S & Brennan, P 2020, 'Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI', Oral Oncology, vol. 108, pp. 104736. https://doi.org/10.1016/j.oraloncology.2020.104736

TY - JOUR

T1 - Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

AU - Kreimer, Aimée R

AU - Chaturvedi, Anil K

AU - Alemany, Laia

AU - Anantharaman, Devasena

AU - Bray, Freddie

AU - Carrington, Mary

AU - Doorbar, John

AU - D'Souza, Gypsyamber

AU - Fakhry, Carole

AU - Ferris, Robert L

AU - Gillison, Maura

AU - Neil Hayes, D

AU - Hildesheim, Allan

AU - Huang, Shao Hui

AU - Kowalski, Luiz P

AU - Lang Kuhs, Krystle A

AU - Lewis, James

AU - Lowy, Douglas R

AU - Mehanna, Hisham

AU - Ness, Andy

AU - Pawlita, Michael

AU - Pinheiro, Maisa

AU - Schiller, John

AU - Shiels, Meredith S

AU - Tota, Joseph

AU - Mirabello, Lisa

AU - Warnakulasuriya, Saman

AU - Waterboer, Tim

AU - Westra, William

AU - Chanock, Stephen

AU - Brennan, Paul

N1 - Published by Elsevier Ltd.

PY - 2020/9/1

Y1 - 2020/9/1

N2 - Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.

AB - Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.

U2 - 10.1016/j.oraloncology.2020.104736

DO - 10.1016/j.oraloncology.2020.104736

M3 - Article (Academic Journal)

C2 - 32502860

SN - 1368-8375

VL - 108

SP - 104736

JO - Oral Oncology

JF - Oral Oncology

ER -

Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

Abstract

Bibliographical note

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this